Publicaciones

@article{Moreno-Montoro2018,

title = {Bioaccessible peptides released by in vitro gastrointestinal digestion of fermented goat milks},

author = {Miriam Moreno-Montoro and Paula Jauregi and Miguel Navarro-Alarcón and Manuel Olalla-Herrera and Rafael Giménez-Martínez and Lourdes Amigo and Beatriz Miralles},

url = {https://doi.org/10.1007/s00216-018-0983-0},

doi = {10.1007/s00216-018-0983-0},

issn = {1618-2650},

year  = {2018},

date = {2018-06-01},

urldate = {2018-06-01},

journal = {Analytical and Bioanalytical Chemistry},

volume = {410},

number = {15},

pages = {3597-3606},

abstract = {In this study, ultrafiltered goat milks fermented with the classical starter bacteria Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus salivarus subsp. thermophilus or with the classical starter plus the Lactobacillus plantarum C4 probiotic strain were analyzed using ultra-high performance liquid chromatography-quadrupole-time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS/MS) and/or high performance liquid chromatography-ion trap (HPLC-IT-MS/MS). Partial overlapping of the identified sequences with regard to fermentation culture was observed. Evaluation of the cleavage specificity suggested a lower proteolytic activity of the probiotic strain. Some of the potentially identified peptides had been previously reported as angiotensin-converting enzyme (ACE) inhibitory, antioxidant, and antibacterial and might account for the in vitro activity previously reported for these fermented milks. Simulated digestion of the products was conducted in the presence of a dialysis membrane to retrieve the bioaccessible peptide fraction. Some sequences with reported physiological activity resisted digestion but were found in the non-dialyzable fraction. However, new forms released by digestion, such as the antioxidant $alpha$s1-casein 144YFYPQL149, the antihypertensive $alpha$s2-casein 90YQKFPQY96, and the antibacterial $alpha$s2-casein 165LKKISQ170, were found in the dialyzable fraction of both fermented milks. Moreover, in the fermented milk including the probiotic strain, the k-casein dipeptidyl peptidase IV inhibitor (DPP-IV) 51INNQFLPYPY60 as well as additional ACE inhibitory or antioxidant sequences could be identified. With the aim of anticipating further biological outcomes, quantitative structure activity relationship (QSAR) analysis was applied to the bioaccessible fragments and led to potential ACE inhibitory sequences being proposed.},

keywords = {Bioaccessible peptides, Fermented goat’s milk, Gastrointestinal digestion, Peptidomics, Tandem mass spectrometry},

pubstate = {published},

tppubtype = {article}

}